Tirzepatide

$39.90

Dual GLP-1 / GIP agonist · metabolic & weight research

Specification: 10 mg / vial

Availability: Usually ships within 2 days.

Lab certificates

SKU: TIR10 Category:
Research product information

Tirzepatide

Structured product, pathway, quality-documentation, and laboratory-handling information.

Product overview

Product
Tirzepatide
SKU
TIR10
Compound
Tirzepatide
Strength
10 mg / vial
Product format
Lyophilised peptide
Quantity per vial
10 mg
Stock
Availability shown at checkout

Compound profile

Receptor or pathway
GLP-1 / GIP receptor agonism
Common areas of scientific investigation
  • Incretin signalling studies
  • Metabolic and appetite pathway studies
  • Body-weight regulation investigation
Known status
Studied in late-stage clinical programmes.
Important limitations of available evidence
Outcomes and tolerability can vary; external real-world claims are not equivalent to controlled trial data.

Quality documentation

Certificate reference
81058
Tested purity
See certificate
Testing method
See certificate
Testing laboratory
Janoshik
Test date
See certificate
Open certificate →

Storage and laboratory handling

Unopened storage
Store according to supplier and certificate instructions.
Light exposure
Keep away from direct light.
Temperature range
Use label and COA guidance for temperature controls.
Lyophilised
Yes
  • Maintain sterile laboratory handling.
  • Track lot/batch and handling logs.

Recommended laboratory accessories

Description

Tirzepatide (Mounjaro®) is a dual GIP and GLP-1 receptor agonist. Phase 3 SURMOUNT trials demonstrated industry-leading weight loss outcomes alongside significant metabolic improvements.

For research use only. Not for human consumption.

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide”

Your email address will not be published. Required fields are marked *